Crinetics Pharmaceuticals, Inc.

formerly CrineticsAcquired

Driving the Next Generation of Endocrinology Care

San Diego, United States · Founded 2015 · $460.3M raised

Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$460.3M
Last Round
$350.0M Venture RoundJan 2026
Rounds
8
Acquisition Date
Jul 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Crinetics Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors, including acromegaly and Cushing's disease. Its proprietary nonpeptide small-molecule platform has produced multiple clinical-stage candidates, including paltusotine (oral SST2 agonist) and atumelnant (oral ACTH antagonist). Founded in San Diego, the company is publicly traded on Nasdaq (CRNX) and has approximately 500–1,000 employees.

Summary

Crinetics Pharmaceuticals, Inc. is a Biotech company based in San Diego, United States, founded in 2015. It has raised $460.3M in total across 8 rounds, most recently a $350.0M Venture Round in Jan 2026. Investors include 5AM Ventures, Vertex Pharmaceuticals and Rock Springs Capital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionJul 2026

Sign up to see all 10 events

Funding: Grant through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Crinetics Pharmaceuticals, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/crinetics-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/crinetics-pharmaceuticals-inc" alt="Crinetics Pharmaceuticals, Inc. on Indexed.vc" width="260" height="76" /></a>